Suppr超能文献

小麦胚芽无细胞蛋白合成系统:新型疟疾疫苗候选物发现的关键工具。

The wheat germ cell-free protein synthesis system: a key tool for novel malaria vaccine candidate discovery.

机构信息

Cell-free Science and Technology Research Center, Ehime University, Matsuyama, Ehime, Japan.

出版信息

Acta Trop. 2010 Jun;114(3):171-6. doi: 10.1016/j.actatropica.2009.10.024. Epub 2009 Nov 11.

Abstract

Malaria kills more than a million people a year, causes malady in about three hundred million people and poses risk to approximately 40% of the world's population living in malarious countries. This disease is re-emerging mainly due to the development of drug-resistant parasites and insecticide-resistant mosquitoes. Therefore, we are now forced to resort to remedy through vaccination. Until now, not even a single licensed malaria vaccine has been developed despite intensive efforts. Even the efficacy of RTS,S, the most advanced and promising vaccine candidate in the pipeline of malaria vaccine development, was only around 50% based on a number of clinical trials. These facts urge malaria researchers to urgently enrich this pipeline, as much as possible, with potential vaccine candidates. With the availability of malaria genome database, the enrichment of this pipeline is possible if we could now employ an efficient protein expression technology to decode the malaria genomic data, without any codon optimization, into quality recombinant proteins. Then, these synthesized recombinant proteins can be characterized and screened for discovering novel potential vaccine targets. The wheat germ cell-free protein synthesis system will be a promising tool to this end. This review highlights the recent successes in synthesizing quality malaria proteins using this tool.

摘要

疟疾每年导致超过 100 万人死亡,使约 3 亿人患病,并对生活在疟疾流行国家的约 40%的世界人口构成威胁。这种疾病主要是由于抗药性寄生虫和抗杀虫剂蚊子的发展而重新出现。因此,我们现在被迫诉诸疫苗接种来进行补救。尽管进行了密集的努力,但迄今为止,甚至没有开发出一种经过许可的疟疾疫苗。即使是 RTS,S,疟疾疫苗开发管道中最先进和最有前途的候选疫苗,根据多项临床试验,其疗效也仅约为 50%。这些事实促使疟疾研究人员尽快尽可能多地利用潜在的疫苗候选物来丰富这一管道。由于有了疟疾基因组数据库,如果我们现在能够利用有效的蛋白质表达技术,在不进行任何密码子优化的情况下,将疟疾基因组数据解码为高质量的重组蛋白,那么就有可能丰富这一管道。然后,这些合成的重组蛋白可以进行表征和筛选,以发现新的潜在疫苗靶点。小麦胚乳无细胞蛋白合成系统将是实现这一目标的有前途的工具。这篇综述强调了最近使用该工具合成高质量疟疾蛋白的成功。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验